5038 J. Agric. Food Chem., Vol. 46, No. 12, 1998
Takahashi et al.
TA 100, and TA 1535) assays to act as antimutagens
against heterocyclic amines including IQ via an inhibi-
tion of cytochrome P-450-mediated metabolic activation
of the mutagens (Barcelo et al., 1996; Hamilton et al.,
1994; Hamilton and Teel, 1996; Knasmuller et al., 1996).
These isothiocyanates can induce phase II detoxifying
enzymes, glutathione S-transferase, and quinone re-
ductase in various mammal tissues (Zhang and Talalay,
1994). In fact, the isothiocyanates showed a clear
suppressive effect on chemical carcinogen-induced mam-
mary tumor models (Wattenberg, 1977, 1987; Morse et
al., 1989, 1991) and, thus, are considered to be cancer-
protective. Indole-3-carbinol, 3,3′-diindolylmethane, and
indole-3-acetonitrile occurring in edible cruciferous
vegetables have been shown to be inhibitors of either
7,12-dimethylbenz[a]anthracene-induced mammary tu-
mor formation in rats or benzo[a]pyrene-induced neo-
plasia of the forestomach in mice (Wattenberg and Loub,
1978), though indole-3-acetonitrile was converted to a
mutagenic 1-nitrosoindole-3-acetonitrile after nitrite
treatment (Wakabayashi et al., 1985).
It is interesting to investigate whether 3,5-disubsti-
tuted 2-thiohydantoins derived from isothiocyanates and
amino acids have an antimutagenic activity as well as
isothiocyanates. The present paper deals with the
antimutagenic properties of 3,5-disubstituted 2-thiohy-
dantoins that have been prepared from AITC or MTBI
and various amino acids against IQ on S. typhimurium
TA 98. This report also describes the effect of pH on
the formation of the 3,5-disubstituted 2-thiohydantoins
and on the growth of some microorganisms.
F igu r e 1. Formation of 3,5-disubstituted 2-thiohydantoins
(1-6). 1: R1 ) allyl; R2 ) isopropyl. 2: R1 ) allyl; R2 ) benzyl.
3: R1 ) allyl; R2 ) indolylmethyl. 4: R1 ) 4-(methylthio)-3-
butenyl; R2 ) isobutyl. 5: R1 ) 4-(methylthio)-3-butenyl; R2
) benzyl. 6: R1 ) 4-(methylthio)-3-butenyl; R2 ) 2-(methyl-
thio)ethyl.
sulfate, was evaporated under reduced pressure to give a solid
residue, which was then recrystallized in EtOH. The crystal
products were analyzed by UV, IR, EI-MS, and NMR spec-
troscopies to confirm their structures (Figure 1). The spectral
data obtained were as follows.
3-Allyl-5-isop r op yl-2-th ioh yd a n toin (1): UV λmax (EtOH)
267 nm; HR-EI-MS m/z (M+) calcd for C9H14ON2S 198.0796,
found 198.0811; LR-EI-MS m/z (%, rel intens.) 198 (M+, 100),
183 (18), 170 (37), 155 (27), 99 (49), 72 (97), 55(40), 41 (54); IR
ν
max (KBr) cm-1 3295 (NH), 1725 (CdO), 1508 (N-CdS), 1171
(CdS); 1H NMR ((CD3)2CO) δ (ppm) 9.13 (1H, s), 5.51-5.59
(1H, m), 4.76-4.95 (2H, m), 4.18-4.21 (2H, m), 4.17-4.18 (1H,
m), 2.19-2.28 (1H, m), 1.08 (3H, d, J ) 6.8 Hz), 0.92 (3H, d,
J ) 6.8 Hz); 13C NMR ((CD3)2CO) δ (ppm) 184.7, 174.3, 132.6,
117.7, 64.9, 43.2, 31.6, 18.6, 16.6.
EXPERIMENTAL PROCEDURES
Ma ter ia ls. A mixture of (E)- and (Z)-MTBI (about 7:1) was
prepared from radish seedlings by our previously described
method (Uda et al., 1990). AITC and IQ (caution: carcinogen)
were purchased from Wako Pure Chemical Inc. (Tokyo, J apan)
and used without further purification. S. typhimurium TA 98
was provided by the National Institute of Health Sciences
(Tokyo, J apan). S9 fraction and cofactors composed of mag-
nesium chloride hexahydrate (80 µmol), potassium chloride
(330 µmol), glucose-6-phosphate (50 µmol), nicotinamide ad-
enine dinucleotide phosphate reduced form (40 µmol), nico-
tinamide adenine dinucleotide reduced form (40 µmol), di-
sodium hydrogen phosphate (842 µmol), and sodium dihydro-
gen phosphate dihydrate (158 µmol) were obtained from
Oriental Yeast Co. (Tokyo, J apan). The cofactors dissolved in
9.0 mL of distilled water were filtrated with a sterilized
membrane filter (0.22 µm) and mixed with 1.0 mL of the S9
fraction. This was immediately used as S9 mix.
In str u m en ta l An a lysis. Ultraviolet (UV) spectra were
obtained in ethanol (EtOH) using a Hitachi 330 double-beam
spectrophotometer. Infrared (IR) spectra were recorded in
potassium bromide (KBr) on a Horiba 1200 FT-IR spectrom-
eter. High-resolution (HR) and low-resolution (LR) electron
impact mass spectral (EI-MS) analysis was done on a J EOL
AX-500 mass spectrometer at 70 eV. 1H and 13C nuclear
magnetic resonance (NMR) spectra were measured in acetone-
d6 ((CD3)2CO) or chloroform-d (CDCl3) on a J EOL EX-400
nuclear magnetic resonance spectrometer using tetramethyl-
silane (TMS) as the internal standard.
3-Allyl-5-ben zyl-2-th ioh yd a n toin (2): UV λmax (EtOH)
269 nm; HR-EI-MS m/z (M+) calcd for C13H14ON2S 246.0827,
found 246.0823; LR-EI-MS m/z (%, rel intens.) 246 (M+, 99),
155 (15), 91 (100), 77 (13), 65 (30), 51(11); IR νmax (KBr) cm-1
3205 (NH), 1747 (CdO), 1521 (N-CdS), 1174 (CdS); 1H NMR
((CD3)2CO) δ (ppm) 9.16 (1H, s), 7.20-7.28 (5H, m), 5.51-5.59
(1H, m), 4.76-4.95 (2H, m), 4.59 (1H, dd, J ) 4.9 & 5.6 Hz),
4.18-4.21 (2H, m), 3.23 (1H, dd, J ) 4.9 & 14.2 Hz), 3.10 (1H,
dd, J ) 5.9 & 14.2 Hz); 13C NMR ((CD3)2CO) δ (ppm) 184.2,
174.1, 135.9, 132.2, 130.7, 129.2, 127.9, 117.1, 60.8, 43.1, 37.3.
3-Allyl-5-(in d olylm eth yl)-2-th ioh yd a n toin (3): UV λmax
(EtOH) 268 nm; LR-EI-MS m/z (%, rel intens.) 285 (M+, 15),
130 (100); IR νmax (KBr) cm-1 3413 (NH), 1732 (CdO), 1533
(N-CdS), 1174 (CdS); 1H NMR ((CD3)2CO) δ (ppm) 10.10 (1H,
s), 9.13 (1H, s), 7.60 (1H, d, J ) 7.8 Hz), 7.36 (1H, d, J ) 7.8
Hz), 7.19 (1H, d, J ) 2.4 Hz), 7.08 (1H, t, J ) 6.8 Hz),7.01
(1H, t, J ) 6.8 Hz), 5.46-5.55 (1H, m), 4.75-4.80 (2H, m),
4.59 (1H, dd, J ) 4.9 & 5.6 Hz), 4.18-4.19 (2H, m), 3.37 (1H,
dd, J ) 6.4 & 14.6 Hz), 3.27 (1H, dd, J ) 4.9 & 14.7 Hz); 13C
NMR ((CD3)2CO) δ (ppm) 184.3, 174.6, 137.4, 132.2, 128.5,
125.0, 122.2, 119.7, 119.4, 117.0, 112.1, 108.9, 60.7, 43.1, 27.5.
3-[4-(Met h ylt h io)-3-b u t en yl]-5-isob u t yl-2-t h ioh yd a n -
toin (4): UV λmax (EtOH) 267 nm; HR-EI-MS m/z (M+) calcd
for C12H20ON2S2 272.1017, found 272.0969; LR-EI-MS m/z (%,
rel intens.) 272 (M+, 19), 225 (57), 100 (91), 85 (100); IR νmax
(KBr) cm-1 3186 (NH), 1749 (CdO), 1527 (N-CdS), 1163 (Cd
S); 1H NMR ((CD3)2CO) δ (ppm) 9.11 (1H, s), 6.08 (1H, d, J )
15.1 Hz), 5.33 (1H, dt, J ) 7.3 & 14.7 Hz), 4.21-4.25 (1H, m),
3.79 (2H, t, J ) 7.3 Hz), 2.42-2.52 (2H, m), 2.21 (3H, s), 1.89-
1.98 (1H, m), 1.57-1.70 (2H, m), 0.97 (3H, d, J ) 6.8 Hz), 0.96
(3H, d, J ) 6.4 Hz); 13C NMR ((CD3)2CO) δ (ppm) 184.4, 175.7,
127.4, 122.5, 58.3, 41.4, 40.8, 32.1, 25.2, 23.4, 21.9, 14.4.
3-[4-(Me t h ylt h io)-3-b u t e n yl]-5-b e n zyl-2-t h ioh yd a n -
toin (5): UV λmax (EtOH) 269 nm; HR-EI-MS m/z (M+) calcd
P r ep a r a tion a n d Str u ctu r a l Con fir m a tion of 3,5-Di-
su bstitu ted 2-Th ioh yd a n toin s. A mixture of MTBI (con-
taining in total of 1.0 mmol of the isomers) or AITC (1.0 mmol)
and the equivalent amount of amino acid (L-valine (Val),
L-luecine (Leu), L-phenylalanine (Phe), L-methionine (Met), and
L-tryptophan (Trp)) in 50 mL of MacIlvaine (citric acid-
disodium hydrogen phosphate) buffer (pH 8.0) was stirred for
48 h at 36 °C. The mixture was extracted with ethyl acetate.
The extract, after drying on a powder of anhydrous sodium